These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30415992)

  • 1. The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis.
    Sand FL; Nielsen DMB; Frederiksen MH; Rasmussen CL; Kjaer SK
    Gynecol Oncol; 2019 Jan; 152(1):208-217. PubMed ID: 30415992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.
    Pouwer AW; Te Grootenhuis NC; Hinten F; de Bock GH; van der Zee AGJ; Melchers WJG; Oonk MHM; de Hullu JA; Hollema H; Bulten J
    Virchows Arch; 2024 Jun; 484(6):985-994. PubMed ID: 37938322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.
    Hay CM; Lachance JA; Lucas FL; Smith KA; Jones MA
    J Low Genit Tract Dis; 2016 Jul; 20(3):252-6. PubMed ID: 26855143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
    Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.
    Carreras-Dieguez N; Saco A; Del Pino M; Marimon L; López Del Campo R; Manzotti C; Fusté P; Pumarola C; Torné A; Garcia A; Rakislova N
    Histopathology; 2023 Jul; 83(1):17-30. PubMed ID: 37099408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.
    Davidson B; Skeie-Jensen T; Holth A; Lindemann K; Toralba Barrameda AM; Lie AK; Wang Y
    Virchows Arch; 2024 Jun; 484(6):951-963. PubMed ID: 37843640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
    Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant Radiation.
    Dohopolski MJ; Horne ZD; Pradhan D; Bhargava R; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):152-160. PubMed ID: 30121234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy.
    Yap ML; Allo G; Cuartero J; Pintilie M; Kamel-Reid S; Murphy J; Mackay H; Clarke B; Fyles A; Milosevic M
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):254-261. PubMed ID: 29449057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
    McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
    Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
    Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
    Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining.
    Höhn AK; Forberger M; Alfaraidi M; Gilks CB; Brambs CE; Höckel M; Hoang L; Singh N; Horn LC
    Gynecol Oncol; 2024 Jun; 185():17-24. PubMed ID: 38342005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
    Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
    Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.
    Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J
    Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of HPV and p16 Status in Men Diagnosed with Penile Cancer: A Systematic Review and Meta-analysis.
    Sand FL; Rasmussen CL; Frederiksen MH; Andersen KK; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1123-1132. PubMed ID: 29987099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of HPV, p16, and p53 protein expression in vaginal cancer: A systematic review.
    Rasmussen CL; Bertoli HK; Sand FL; Kjaer AK; Thomsen LT; Kjaer SK
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2144-2156. PubMed ID: 34546565
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Lozar T; Keske A; Dube Mandishora RS; Yu Q; Bailey A; Xu J; Tommasino M; McGregor SM; Lambert PF; Gheit T; Fitzpatrick MB
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.